A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC

NCT06177925 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Neoplasms
Lung Diseases
Respiratory Tract Diseases
Carcinoma, Bronchogenic
Bronchial Neoplasms
Lung Neoplasms
Small Cell Lung Carcinoma

Interventions

DRUG: Adebrelimab
DRUG: Carboplatin/Cisplatin
DRUG: Etoposide
RADIATION: Radiation therapy

Sponsor

Nanfang Hospital, Southern Medical University

Collaborators

[object Object]